title: Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
abstract: OBJECTIVE
  This study was designed to: [1] measure, for the first time, metastin (kisspeptin) levels in women with polycystic ovary syndrome (PCOS), a condition associated with hypersecretion of LH and hyperandrogenemia; and [2] investigate the possible correlations between metastin and PCOS-related reproductive and metabolic disturbances.
  
  
  METHODS
  Clinical study.
  
  
  METHODS
  University hospital.
  
  
  METHODS
  Twenty-eight obese and overweight (body mass index [BMI] >25 kg/m2) women with PCOS, 28 normal weight (BMI <25 kg/m2) women with the syndrome, and 13 obese and overweight controls (ovulatory women without clinical or biochemical hyperandrogenemia) were selected.
  
  
  METHODS
  Blood samples were collected between day 3 and day 6 of a spontaneous bleeding episode in the PCOS groups and a menstrual cycle of the controls, at 9:00 AM, after an overnight fast.
  
  
  METHODS
  Circulating levels of LH, FSH, PRL, T, Delta4-androstenedione (A), DHEAS, 17alpha-OH-P, sex hormone-binding globulin (SHBG), insulin, glucose, and metastin were measured.
  
  
  RESULTS
  Both normal weight women with PCOS and obese controls were less insulin resistant and had significantly higher metastin levels, compared to obese and overweight women with the syndrome. Plasma kisspeptin levels were negatively correlated with BMI, free androgen index, and indices of insulin resistance.
  
  
  CONCLUSIONS
  These results indicate that metastin is negatively associated with free androgen levels. The PCOS-associated insulin resistance and consequent hyperinsulinemia probably contribute to this effect by [1] stimulating androgen synthesis by the polycystic ovary (PCO) and [2] suppressing SHBG production in the liver.
authors.affiliation: Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Panidis
authors.forename: David
authors.initials: D
authors.lastname: Rousso
authors.forename: George
authors.initials: G
authors.lastname: Koliakos
authors.forename: Anargyros
authors.initials: A
authors.lastname: Kourtis
authors.forename: Ilias
authors.initials: I
authors.lastname: Katsikis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Farmakiotis
authors.forename: Elissavet
authors.initials: E
authors.lastname: Votsi
authors.forename: Evanthia
authors.initials: E
authors.lastname: Diamanti-Kandarakis
mesh_terms: D000293:Adolescent; D000328:Adult; D000728:Androgens / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006115:Greece / Q000453:epidemiology; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D059648:Kisspeptins; D009765:Obesity / Q000097:blood* / Q000453:epidemiology*; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000453:epidemiology*; D013223:Statistics as Topic; D025521:Tumor Suppressor Proteins / Q000097:blood*
chemical_list: D000728:Androgens; D015415:Biomarkers; D007328:Insulin; C106628:KISS1 protein, human; D059648:Kisspeptins; D025521:Tumor Suppressor Proteins